These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 454028)

  • 1. The use of prostaglandin E1 and Blalock-Taussig shunts in neonates with cyanotic congenital heart disease.
    Browdie DA; Norberg W; Agnew R; Altenburg B; Ignacio R; Hamilton C
    Ann Thorac Surg; 1979 Jun; 27(6):508-13. PubMed ID: 454028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified Blalock-Taussig shunt following long-term administration of prostaglandin E1 for ductus-dependent neonates with cyanotic congenital heart disease.
    Yokota M; Muraoka R; Aoshima M; Nomoto S; Shiraishi Y; Kyoku I; Kitano M; Shimada I; Nakano H; Ueda K
    J Thorac Cardiovasc Surg; 1985 Sep; 90(3):399-403. PubMed ID: 4033176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic-pulmonary shunts in infants and children. Early and late results.
    Lamberti JJ; Carlisle J; Waldman JD; Lodge FA; Kirkpatrick SE; George L; Mathewson JW; Turner SW; Pappelbaum SJ
    J Thorac Cardiovasc Surg; 1984 Jul; 88(1):76-81. PubMed ID: 6204171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintaining patency of the ductus-arteriosus for palliation of cyanotic congenital cardiac malformations. The use of prostaglandin E1 and formaldehyde infiltration of the ductal wall.
    Hatem J; Sade RM; Upshur JK; Hohn AR
    Ann Surg; 1980 Jul; 192(1):124-8. PubMed ID: 7406557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Blalock-Taussig shunt in infants: standard versus modified.
    Ullom RL; Sade RM; Crawford FA; Ross BA; Spinale F
    Ann Thorac Surg; 1987 Nov; 44(5):539-43. PubMed ID: 3675059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergency transcatheter balloon recanalization of acutely thrombosed modified Blalock-Taussig shunts.
    Sivakumar K; Anil SR; Ravichandra M; Natarajan KU; Kamath P; Kumar RK
    Indian Heart J; 2001; 53(6):743-8. PubMed ID: 11838928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Blalock-Taussig shunt in the newborn infant.
    Smith VC; Caggiano AV; Knauf DG; Alexander JA
    J Thorac Cardiovasc Surg; 1991 Oct; 102(4):602-5. PubMed ID: 1717795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified Blalock-Taussig shunt versus ductal stenting for palliation of cardiac lesions with inadequate pulmonary blood flow.
    McMullan DM; Permut LC; Jones TK; Johnston TA; Rubio AE
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):397-401. PubMed ID: 24071469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blalock-Taussig shunts in infants less than 6 months of age with special reference to the long-term administration of prostaglandin E1].
    Yoshimura N; Yamaguchi M; Ohashi H; Imai M; Oshima Y; Yamashita T; Toyoda Y; Mito H; Chung HN; Hosokawa Y
    Nihon Kyobu Geka Gakkai Zasshi; 1993 Oct; 41(10):2001-5. PubMed ID: 8228400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of prostaglandin E1 in cardiac malformations in the newborn infant].
    Sassolas F; Bozio A; Andre M; Jocteur-Monrozier D; Champsaur G; Normand J
    Pediatrie; 1984 Jun; 39(4):245-52. PubMed ID: 6504667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified Blalock-Taussig shunt in newborn infants.
    Ilbawi MN; Grieco J; DeLeon SY; Idriss FS; Muster AJ; Berry TE; Klich J
    J Thorac Cardiovasc Surg; 1984 Nov; 88(5 Pt 1):770-5. PubMed ID: 6492843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The modified blalock-taussig shunt using microporous expanded polytetrafluoroethylene (PTFE).
    Lawless CE; Smith EE; Hallidie-Smith K; Sapsford RN
    J Cardiovasc Surg (Torino); 1982; 23(4):287-92. PubMed ID: 7107686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blalock-Taussig shunts in newborn infants].
    Sawa Y; Shimazaki Y; Iio M; Hirose O; Oka N; Nakada T; Yagihara T
    Nihon Kyobu Geka Gakkai Zasshi; 1986 Mar; 34(3):343-8. PubMed ID: 3722934
    [No Abstract]   [Full Text] [Related]  

  • 14. Noninvasive evaluation of Blalock-Taussig shunts: determination of patency and differentiation from patent ductus arteriosus by doppler echocardiography.
    Stevenson JG; Kawabori I; Bailey WW
    Am Heart J; 1983 Nov; 106(5 Pt 1):1121-32. PubMed ID: 6637769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E-type prostaglandins: a new emergency therapy for certain cyanotic congenital heart malformations.
    Olley PM; Coceani F; Bodach E
    Circulation; 1976 Apr; 53(4):728-31. PubMed ID: 56243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical manipulation of the ductus arteriosus.
    Elliott RB; Starling MB; Neutze JM
    Lancet; 1975 Jan; 1(7899):140-2. PubMed ID: 46053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclavian-pulmonary artery shunts with polytetrafluorethylene interposition grafts.
    Bove EL; Sondheimer HM; Kavey RE; Byrum CJ; Blackman MS; Parker FB
    Ann Thorac Surg; 1984 Jan; 37(1):88-91. PubMed ID: 6691743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Magnetic resonance imaging: evaluation of the Blalock-Taussig shunts and anatomy of the pulmonary artery].
    Ichida F; Hashimoto I; Miyazaki A; Tsubata S; Okada T; Murakami A; Nakajima A; Futatsuya R
    J Cardiol; 1992; 22(4):669-78. PubMed ID: 1343633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative angiographic assessment of modified Blalock-Taussig shunts using expanded polytetrafluoroethylene (Gore-Tex).
    McKay R; de Leval MR; Rees P; Taylor JF; Macartney FJ; Stark J
    Ann Thorac Surg; 1980 Aug; 30(2):137-45. PubMed ID: 7416836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E1 in infants with congenital heart disease: Indian experience.
    Saxena A; Sharma M; Kothari SS; Juneja R; Reddy SC; Sharma R; Bhan A; Venugopal P
    Indian Pediatr; 1998 Nov; 35(11):1063-9. PubMed ID: 10216540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.